Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response.

Journal for immunotherapy of cancer·2026
Same author

Overall Survival of Patients With PSA-Recurrent Prostate Cancer: Long-Term Analysis of a Randomized Phase 2 Trial of pTVG-HP DNA Vaccine Versus Placebo.

Clinical genitourinary cancer·2026
Same author

Plasmid DNA vaccines encapsulated in lipid nanoparticles elicit STING-dependent type 1 interferon release.

Molecular therapy. Advances·2026
Same author

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC).

Journal for immunotherapy of cancer·2026
Same author

Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.

Journal for immunotherapy of cancer·2026
Same author

The lack of legal protections in the United States to prevent commercializing the dead for education and research: Consequences and risks to anatomists.

Anatomical sciences education·2026

Related Experiment Video

Updated: May 2, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

8.3K

DNA Vaccines for Prostate Cancer.

Douglas G McNeel1, Jordan T Becker1, Laura E Johnson1

  • 1Department of Medicine, University of Wisconsin Carbone Cancer Center, 1111 Highland Avenue, Madison, WI 53705, USA.

Current Cancer Therapy Reviews
|March 4, 2014
PubMed
Summary

DNA vaccines effectively induce T cells for cancer immunization, offering manufacturing and safety benefits. Despite challenges in transfection efficiency, ongoing research and clinical trials show promise for prostate cancer immunotherapy.

Keywords:
DNA vaccinesclinical trialsprostate cancertumor antigens

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

10.8K

Related Experiment Videos

Last Updated: May 2, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

8.3K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.5K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

10.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Oncology

Background:

  • Plasmid DNA vaccines are a promising approach for immunization, particularly against tumors.
  • They offer advantages in manufacturing simplicity and safety compared to other anti-tumor vaccines.
  • However, low transfection efficiency and immunogenicity remain significant challenges.

Purpose of the Study:

  • To review DNA vaccines as a method for antigen delivery in cancer immunotherapy.
  • To discuss the advantages and disadvantages of DNA vaccine technology.
  • To summarize preclinical and clinical trial data for DNA vaccines in prostate cancer treatment.

Main Methods:

  • Review of preclinical models demonstrating anti-tumor efficacy of DNA vaccines.
  • Analysis of clinical trial data for DNA vaccines in prostate cancer.
  • Discussion of strategies to improve DNA vaccine immunogenicity and anti-tumor effects.

Main Results:

  • Preclinical studies show anti-tumor efficacy for DNA vaccines.
  • Clinical trials for prostate cancer DNA vaccines demonstrate safety and immunological effects.
  • Ongoing efforts focus on enhancing immunogenicity and therapeutic outcomes.

Conclusions:

  • DNA vaccines are a viable strategy for prostate cancer immunotherapy, with demonstrated safety and immunogenicity in clinical trials.
  • Further research is needed to optimize DNA vaccine platforms for improved anti-tumor responses.
  • DNA vaccines hold potential for advancing cancer treatment through enhanced immunization strategies.